LEADER 03944nam  22007095  450 
001 9910502614803321
005 20251113201357.0
010   $a3-030-78663-3
024 7 $a10.1007/978-3-030-78663-2
035   $a(CKB)5140000000012939
035   $a(MiAaPQ)EBC6747475
035   $a(Au-PeEL)EBL6747475
035   $a(OCoLC)1274056808
035   $a(PPN)258301783
035   $a(DE-He213)978-3-030-78663-2
035   $a(EXLCZ)995140000000012939
100   $a20211007d2021      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aDiagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy $eA MASCC Book /$fedited by Maryam Lustberg, Charles Loprinzi
205   $a1st ed. 2021.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2021.
215   $a1 online resource (265 pages) $cillustrations
225 1 $aBiomedical and Life Sciences Series
311 08$a3-030-78662-5 
320   $aIncludes bibliographical references.
327   $aNatural History of Chemotherapy Induced Neuropathy -- Predisposing factors for the development of CIPN -- Evaluation of Chemotherapy-Induced Peripheral Neuropathy -- Preventive Strategies for Chemotherapy-in-duced Peripheral Neuropathy -- Prevention of CIPN ? Current Clinical Data and Future Directions -- Treatment of established CIPN: basic science and animal models -- Pharmacological Treatment of Established CIPN -- Systematic review of exercise for prevention and management of chemotherapy-induced peripheral neuropathy -- Clinical and practical recommendations in the use of exercise, physical therapy, and occupational therapy for chemotherapy-induced peripheral neuropathy -- Natural course of neurotoxicity after immune checkpoint inhibitor (ICI) exposure -- Ants and Needles and Pins ? Living with Neuropathy.
330   $aThis book comprehensively examines chemotherapy-induced peripheral neuropathy (CIPN), a common dose-limiting condition that negatively affects both the quality of life of cancer patients and disease outcomes. CIPN remains a challenging area for both clinical care and research, as there are multiple unresolved issues. Written by leading international experts, the book discusses the natural history of CIPN, the latest predictors of toxicity, instruments for evaluating symptoms, and prevention/therapeutic strategies, as well as patients? experiences of this common clinical syndrome. Lastly it highlights avenues for future research to enhance our understanding of CIPN. Providing essential information on the management of CIPN and the latest research in the field, this book is a valuable resource for researchers and healthcare providers working with patients with various malignant diseases.
410  0$aBiomedical and Life Sciences Series
606   $aCancer$xTreatment
606   $aNeurosciences
606   $aNeurophysiology
606   $aCancer
606   $aNervous system$xRegeneration
606   $aCancer Therapy
606   $aNeuroscience
606   $aNeurophysiology
606   $aCancer Biology
606   $aRegeneration and Repair in the Nervous System
615  0$aCancer$xTreatment.
615  0$aNeurosciences.
615  0$aNeurophysiology.
615  0$aCancer.
615  0$aNervous system$xRegeneration.
615 14$aCancer Therapy.
615 24$aNeuroscience.
615 24$aNeurophysiology.
615 24$aCancer Biology.
615 24$aRegeneration and Repair in the Nervous System.
676   $a616.87
702   $aLustberg$b Maryam
702   $aLoprinzi$b Charles
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910502614803321
996   $aDiagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy$92568804
997   $aUNINA